Organigram Global (OGI) Profit After Tax (2018 - 2026)
Organigram Global (OGI) posted quarterly Profit After Tax of $13.9 million for Q1 2026, down 53.06% year-on-year from $29.6 million in Q1 2025, and up 3973.99% on a QoQ basis from -$358543.1 in Q4 2025.
Organigram Global (OGI) Profit After Tax (2018 - 2026) Analysis & Trends
Organigram Global (OGI) has reported Profit After Tax for 7 consecutive years, with $13.9 million the latest figure, recorded in Q1 2026.
- Quarterly Profit After Tax fell 53.06% year-over-year to $13.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $26.7 million (up 191.76% YoY) and the FY2025 annual result came in at $13.1 million, changed N/A from the prior year.
- Profit After Tax climbed to $13.9 million in Q1 2026 per OGI's latest filing, from -$358543.1 in the prior quarter.
- Over the last five years, Profit After Tax for OGI reached as high as $29.6 million in Q1 2025 and fell as low as -$16.4 million in Q4 2024.
- A 3-year average of $6.7 million and a median of $6.8 million in 2025 frame the typical range for Profit After Tax.
- Annual changes were most pronounced in 2025 — Profit After Tax surged 97.82% — and 2026, when it sank 53.06%.
- Year by year, Profit After Tax stood at -$16.4 million in 2024, then jumped by 97.82% to -$358543.1 in 2025, then soared by 3973.99% to $13.9 million in 2026.
- According to Business Quant data, Profit After Tax over the past three periods registered $13.9 million, -$358543.1, and $29.6 million for Q1 2026, Q4 2025, and Q1 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 369.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 601.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -2.35 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 274.90 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 176.40 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 197.90 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 57.00 Mn |
| 10 | Organigram Global | 89.89 Mn | 122.96 Mn | 28.97 Mn | 13.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.89 Mn |
| Dec 31, 2025 | -358,543.14 |
| Mar 31, 2025 | 29.59 Mn |
| Dec 31, 2024 | -16.43 Mn |
| May 31, 2021 | -104.73 Mn |
| Feb 28, 2021 | 100.73 Mn |
| Nov 30, 2020 | -34.34 Mn |
| Aug 31, 2020 | -173.93 Mn |
| May 31, 2020 | -89.87 Mn |
| Feb 29, 2020 | 6.83 Mn |
| Nov 25, 2019 | 15.25 Mn |
| Aug 31, 2019 | -17.01 Mn |
| May 31, 2019 | 7.60 Mn |
| Feb 28, 2019 | 6.39 Mn |
| Nov 30, 2018 | 29.52 Mn |
| Aug 31, 2018 | 16.46 Mn |
| May 31, 2018 | 2.82 Mn |